Agios Pharmaceuticals
AGIO
AGIO
184 hedge funds and large institutions have $3.63B invested in Agios Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 39 funds opening new positions, 50 increasing their positions, 62 reducing their positions, and 27 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
11% less call options, than puts
Call options by funds: $27.3M | Put options by funds: $30.7M
19% less repeat investments, than reductions
Existing positions increased: 50 | Existing positions reduced: 62
60% less funds holding in top 10
Funds holding in top 10: 5 → 2 (-3)
Holders
184
Holding in Top 10
2
Calls
$27.3M
Puts
$30.7M
Top Buyers
| 1 | +$98.9M | |
| 2 | +$71.3M | |
| 3 | +$31.5M | |
| 4 |
Northern Trust
Chicago,
Illinois
|
+$18.1M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$16.2M |
Top Sellers
| 1 | -$79.2M | |
| 2 | -$36.8M | |
| 3 | -$24M | |
| 4 |
Millennium Management
New York
|
-$12.1M |
| 5 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
-$10.1M |